Bio Essence (BIOE) Debt to Equity (2020 - 2024)
Bio Essence has reported Debt to Equity over the past 5 years, most recently at -$0.9 for Q1 2024.
- For Q1 2024, Debt to Equity fell 8783.16% year-over-year to -$0.9; the TTM value through Mar 2024 reached -$0.9, down 8783.16%, while the annual FY2023 figure was -$0.37, 3118.2% down from the prior year.
- Debt to Equity for Q1 2024 was -$0.9 at Bio Essence, down from -$0.37 in the prior quarter.
- Over five years, Debt to Equity peaked at -$0.01 in Q1 2023 and troughed at -$0.98 in Q3 2021.
- A 5-year average of -$0.34 and a median of -$0.02 in 2021 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: surged 98.64% in 2022 and later plummeted 8783.16% in 2024.
- Year by year, Debt to Equity stood at -$0.74 in 2020, then surged by 97.24% to -$0.02 in 2021, then surged by 43.43% to -$0.01 in 2022, then crashed by 3118.2% to -$0.37 in 2023, then plummeted by 140.89% to -$0.9 in 2024.
- Business Quant data shows Debt to Equity for BIOE at -$0.9 in Q1 2024, -$0.37 in Q4 2023, and -$0.02 in Q3 2023.